Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

Team Acquisition Completion

19 Oct 2020 07:00

RNS Number : 3843C
Polar Capital Holdings PLC
19 October 2020
 

19 October 2020

 

Polar Capital Holdings plc completes the acquisition of International and World equity strategies

 

Polar Capital Holdings plc ("Polar Capital"), the specialist active asset management group, today announces the completion of the acquisition of the International Value and World Value equity team led by Pierre Py and Greg Herr ("the Managers") from the Los Angeles-based asset manager First Pacific Advisors, LP.

- A new joint venture, Phaeacian Partners LLC ("Phaeacian"), has been established

- Two 1940 Act mutual funds - the FPA Paramount Fund, Inc. and the FPA International Value Fund - have been reorganised into the Phaeacian Global Value Fund and the Phaeacian Accent International Value Fund

- Phaeacian assets under management at the transition total $545m (as at the end of September 2020)

The completion of the transaction provides the Managers and Polar Capital with the opportunity to build Phaeacian into a significant presence in the International (global ex-US) and Global equity sectors.

The Managers bring an exceptional performance record. Over five years to end September 2020, the FPA International Value Fund is five-star rated by Morningstar and the FPA Paramount Fund is four-star rated. Additionally, International Value is the top ranked fund in its Morningstar sector over three and five years and holds a Morningstar Bronze rating*. All performance track records and ratings have been ported across to Phaeacian.

The launch and establishment of Phaeacian is consistent with Polar Capital's strategy of diversifying its product offering into top-performing international and global equity strategies, as with its Emerging Markets Stars business, with appeal in the institutional as well as wholesale channels, particularly in North America.

 

Gavin Rochussen, CEO, Polar Capital said:

"The establishment of Phaeacian Partners is the next step in Polar's strategy to build out our international and global products and our institutional presence in North America.

 

"The strategies that Pierre and Greg will manage for us, as well as their investment philosophy, are a natural fit with Polar Capital's investment-led approach to managing our clients' money. We will provide Phaeacian with a best-in-class operational structure, allowing them the investment autonomy to build on their impressive track record and proven, repeatable investment process. They are an excellent addition to Polar Capital, and I am looking forward to working with them."

 

Pierre Py and Greg Herr said:

"We are thoroughly looking forward to working with Polar Capital. The partnership allows us to focus on generating exceptional, investment-led returns for our clients, while benefiting from the outstanding business support Polar Capital can provide. It is an ideal fit for us in terms of operating environment and culture."

 

*Source: Morningstar as at 30 September 2020. FPA International Value is in the Morningstar Foreign Small/Mid Blend Morningstar category and FPA Paramount in the Morningstar World Large Stock category.

For further information please contact:

Polar Capital + 44 (0)20 7227 2700

Gavin Rochussen (Chief Executive)

John Mansell (Executive Director)

Samir Ayub (Finance Director)

 

Numis Securities Limited - Nomad and Joint Broker + 44 (0) 20 7260 1000

Charles Farquhar

Stephen Westgate

Kevin Cruickshank (QE)

 

Peel Hunt LLP - Joint Broker +44 (0)20 7418 8893

Andrew Buchanan

Rishi Shah

 

Camarco +44 (0)20 3757 4984

Ed Gascoigne-Pees

Georgia Edmonds

Monique Perks

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBUBDGGXBDGGL
Date   Source Headline
1st Jul 202111:07 amRNSDividend Declaration
1st Jul 202110:26 amRNSDirector Declaration
1st Jul 20217:00 amRNSGroup Audited Results for year ended 31 March 2021
29th Jun 20213:53 pmRNSForm 8.3 - Ultra Electronics Holdings PLC
7th Jun 20217:00 amRNSNotice of Results
1st Jun 20217:00 amRNSTotal Voting Rights
26th May 20215:35 pmRNSDirector/PDMR Shareholding
21st May 20212:21 pmRNSDirector/PDMR Shareholding
20th May 202111:36 amRNSIssue of Equity
20th May 202110:38 amRNSHolding(s) in Company
19th May 20217:00 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
17th May 202112:45 pmRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSIssue of Equity
16th Apr 20217:00 amRNSDirector/PDMR Shareholding
15th Apr 20217:00 amRNSAuM Update
13th Apr 20214:27 pmRNSHolding(s) in Company
1st Apr 202110:44 amRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights
25th Mar 20215:45 pmRNSHolding(s) in Company
18th Mar 20214:08 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSCompletion of Dalton SP LLP Acquisition
26th Feb 20214:33 pmRNSDirector/PDMR Shareholding
26th Feb 20214:32 pmRNSTotal Voting Rights
23rd Feb 20217:00 amRNSIssue of Equity
1st Feb 20215:35 pmRNSIssue of Equity
1st Feb 20217:00 amRNSBlock listing Interim Review
1st Feb 20217:00 amRNSTotal Voting Rights
25th Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSIssue of Equity
20th Jan 20215:25 pmRNSDirector/PDMR Shareholding
20th Jan 20215:22 pmRNSIssue of Equity
19th Jan 20219:39 amRNSIssue of Equity
18th Jan 20217:00 amRNSDirector/PDMR Shareholding
15th Jan 20217:00 amRNSIssue of Equity
14th Jan 20217:00 amRNSAuM Update
17th Dec 20207:00 amRNSAcquisition of Dalton Strategic Partnership LLP
4th Dec 202010:08 amRNSIssue of Equity
1st Dec 20207:00 amRNSTotal Voting Rights
25th Nov 20203:36 pmRNSIssue of Equity
19th Nov 20207:00 amRNSUnaudited interim results
16th Nov 20202:13 pmRNSForm 8.3 - CPL RESOURCES PLC
2nd Nov 20208:51 amRNSTotal Voting Rights
23rd Oct 20204:26 pmRNSNotice of Results
19th Oct 20207:00 amRNSTeam Acquisition Completion
8th Oct 20204:48 pmRNSIssue of Equity
8th Oct 20207:00 amRNSAuM Update
29th Sep 202012:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.